These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19800526)

  • 1. Topical cyclosporine.
    Sinha R; Vishnu S; Sharma N; Vajpayee RB
    Ophthalmology; 2009 Oct; 116(10):2038-38.e1. PubMed ID: 19800526
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes.
    Javadi MA; Feizi S; Karbasian A; Rastegarpour A
    Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M
    Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial.
    Sinha R; Jhanji V; Verma K; Sharma N; Biswas NR; Vajpayee RB
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1167-72. PubMed ID: 20414783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
    Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS
    Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Penetrating keratoplasty in high-risk children: prevention of graft rejection].
    Pleskova AV; Khvatova AV
    Vestn Oftalmol; 2014; 130(3):17-20. PubMed ID: 25098116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%.
    Rao SN
    Am J Ophthalmol; 2006 Apr; 141(4):771-2. PubMed ID: 16564829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
    Unal M; Yücel I
    Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A in perforating keratoplasty.
    Sundmacher R; Reinhard T
    Cesk Slov Oftalmol; 1995 Oct; 51(5):271-6. PubMed ID: 8948156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty.
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Jpn J Ophthalmol; 2000; 44(3):302-5. PubMed ID: 10913651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cyclosporin: a treatment for corneal graft rejection.
    Ross AH; Cook SD
    Clin Exp Ophthalmol; 2008 Jul; 36(5):399-400. PubMed ID: 18925911
    [No Abstract]   [Full Text] [Related]  

  • 13. Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer.
    Sonmez B; Beden U; Erkan D
    Int Ophthalmol; 2009 Apr; 29(2):123-5. PubMed ID: 18094939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis.
    Perry HD; Doshi SJ; Donnenfeld ED; Bai GS
    Cornea; 2002 Mar; 21(2):161-3. PubMed ID: 11862086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcome of topical cyclosporine treatment following penetrating keratoplasty].
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Nippon Ganka Gakkai Zasshi; 1999 Apr; 103(4):306-10. PubMed ID: 10339976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2%].
    Alalwani H; Omer Saleh B; Rocher N; Renard G; Bourges JL; Legeais JM
    J Fr Ophtalmol; 2010 Dec; 33(10):710-4. PubMed ID: 21093105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of topical cyclosporine.
    Kaan G; Ozden O
    Ann Ophthalmol; 1993 May; 25(5):182-6. PubMed ID: 8517589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Tacrolimus as Adjuvant Therapy to Corticosteroids in Acute Endothelial Graft Rejection After Penetrating Keratoplasty: A Randomized Controlled Trial.
    Hashemian MN; Latifi G; Ghaffari R; Ghassemi H; Zarei-Ghanavati M; Mohammadi SF; Yasseri M; Fallah Tafti MR; Tafti ZF
    Cornea; 2018 Mar; 37(3):307-312. PubMed ID: 29215395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative approach to topical cyclosporine therapy.
    Williams DL
    Eye (Lond); 1997; 11 ( Pt 4)():453-64. PubMed ID: 9425407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical immunosuppressives after penetrating keratoplasty].
    Birnbaum F; Reis A; Reinhard T
    Ophthalmologe; 2007 May; 104(5):381-7. PubMed ID: 17387481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.